Inhalation

INH0426

Issue link: https://www.e-digitaleditions.com/i/1544305

Contents of this Issue

Navigation

Page 43 of 47

Twenty-five to 50% of healthy infants born at term are infected with respiratory syncytial virus (RSV) in the first year of life. In addition, 2-3% have small airway bronchiolitis and lower respiratory tract infection that requires hospital admission. Scientists have previously shown a link between RSV and asthma but proving the virus causes the condition has been difficult. 42 April 2026 Inhalation BACK PAGE Early RSV in human infants can increase risk of childhood asthma; early RSV prevention study in mice showed promise Twenty-five to 50% of healthy infants born at term are infected with respiratory syncytial virus (RSV) in the first year of life. In addition, 2-3% have small airway bronchiolitis and lower respira- tory tract infection that requires hospital admission. Scientists have previously shown a link between RSV and asthma but proving the virus causes the con- dition has been difficult. Now, Belgian scientists from the Vlaams Instituut voor Biotechnol- ogie (VIB) and Ghent University (UGent) Center for Inflammation Research (IRC), together with Danish colleagues, have discov- ered evidence that infection with RSV early in infancy may signifi- cantly increase the risk of develop- ing childhood asthma, particularly for children with one or both par- ents who have asthma or allergy. ey have also determined how an early viral infection can mag- nify the impact of inherited allergy risk. Furthermore, their study, published in Science Immunology, suggests that protecting newborns against RSV could substantially reduce asthma cases later in life. "Childhood asthma is a com- plex disease with many contrib- uting factors," said Professor Bart Lambrecht, MD, PhD, sci- ence director at IRC and senior author of the study. "We found that early-life RSV infection and genetic allergy risk interact in a very specific way that pushes the immune system toward asthma. e encouraging news is that this process can be prevented." Utilizing patient data and a mouse model Utilizing the Danish National Patient Registry, the research- ers analyzed data on more than 24,000 RSV-related hospitaliza- tions among approximately 1.5 million infants younger than 6 months of age as well as data on the receipt of specialized asthma care among parents and their chil- dren from 1994 to 2018. e team also evaluated inhaler and nasal corticosteroid prescriptions from the Danish National Prescription Registry and the link between outcomes and age and parents and children using the Danish Civil Registration System. Children were followed for asthma develop- ment up to 24 years of age. To study causality between RSV and asthma, the research- ers utilized a mouse model of the closely related pneumovirus (PVM) and the house dust mite (HDM) allergen. Patient data: Early RSV increased risk of childhood asthma Analysis of patient data showed that children born to nonasth- matic parents and hospitalized for RSV bronchiolitis during their first 6 months of life had a three- fold higher cumulative risk of asthma than those not hospital- ized for RSV in the same period (hazard ratio [HR] 3.32). In addition, children born to an asthmatic parent and not hospi- talized for RSV bronchiolitis were at nearly double the risk of asthma than those born to parents with- out asthma (HR 2.06 for children of an asthmatic mother; HR 1.71 for an asthmatic father), confirm- ing the strong influence of paren- tal asthma on this risk. e highest cumulative asthma risk was seen in children both hos- pitalized for RSV and born to an asthmatic mother (HR 5.38) or asthmatic father (HR 4.73) com-

Articles in this issue

view archives of Inhalation - INH0426